XOMA Royalty Corp
OJEMDA
Date
TBD
FDA decision · Date TBD estimated
What's at stake
The FDA's approval decision on OJEMDA for its lead indication is due Date TBD. A green light opens the market; a complete response letter (CRL) usually sinks the stock.
Primary source
· SEC 8-K
verified 13h ago
“Potential for EMA decisions on OJEMDA ™ and MIPLYFFA ™ marketing authorization applications”